Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Zuchun Zhao"'
Autor:
Dao Lentz, Marc Whitlow, Kenneth J. Shaw, Karna Lyn Sacchi, Sakata Steven T, Janette Walters, Kathy White, Joseph Post, Bin Ye, Wheeseong Lee, Kochanny Monica, Elena Ho, Amy Liang, Ron Vergona, Janice Ewing, Morrissey Michael M, Karanjawala Rushad E, Gary Phillips, Zuchun Zhao, Brian D. Griedel, Babu Subramanyam, Marc Adler
Publikováno v:
Bioorganic & Medicinal Chemistry. 15:2127-2146
A series of thiophene-containing non-amidine factor Xa inhibitors is described. Simple methyl-substituted thiophene analogs were relatively weak inhibitors. However, introduction of hydrophilic substituents at C-4 or C-5 of the thiophene afforded inh
Autor:
Kenneth J. Shaw, Bauer Shawn M, Amy Liang, Brad O. Buckman, Wheeseong Lee, Brian D. Griedel, Ghannam Ameen F, Qingyu Wu, Zuchun Zhao, Khim Seock-Kyu, Karna Lyn Sacchi, Bin Ye
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:3361-3365
Compound 2 was identified by high throughput screening as a novel PAI-1 inhibitor. Systematic optimization of the A, B, and C segments of 2 resulted in the identification of a more potent compound 39 with good oral bioavailability. The synthesis and
Autor:
Ghannam Ameen F, Monahan Sean D, H. Daniel Perez, Susan Harvey, Wei Xu, Laura Dunning, Joseph Hesselgesser, Richard Horuk, Jun Shen, Elena Ho, Ng Howard P, Ron Vergona, Mary Rosser, Karen May, Babu Subramanyam, Imadul Islam, Cornell Mallari, John G. Bauman, Zuchun Zhao, Huynh Oanh, R. Michael Snider, Guo-Ping Wei, Ken Shaw, Meina Liang, Brad O. Buckman, Dennis D. Taub, Michael M. Morrissey
Publikováno v:
Journal of Biological Chemistry. 275:19000-19008
The CC chemokine receptor-1 (CCR1) is a prime therapeutic target for treating autoimmune diseases. Through high capacity screening followed by chemical optimization, we identified a novel non-peptide CCR1 antagonist, R-N-[5-chloro-2-[2-[4-[(4-fluorop
Autor:
Marc Whitlow, Morrissey Michael M, Amy Liang, Brian D. Griedel, Jerry L. Dallas, Arnaiz Damian O, Joseph Post, Zuchun Zhao, Kenneth J. Shaw, Lan Trinh, Sakata Steven T
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 10:963-966
Inhibitors based on the benzimidazole scaffold showed subnanomolar potency against Factor Xa with 500–1000-fold selectivity against thrombin and 50–100-fold selectivity against trypsin. The 2-substituent on the benzimidazole ring had a strong imp
Autor:
Lan Trinh, Sunil K. Koovakkat, Amy Liang, Arnaiz Damian O, Zuchun Zhao, Marc Whitlow, Kenneth J. Shaw
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 10:957-961
A series of indole and carbazole based inhibitors of factor Xa (FXa) has been investigated. The most potent compound inhibits FXa with a Ki of 0.2 nM and has 900- and 750-fold selectivity over thrombin and trypsin, respectively.
Autor:
Sunil K. Koovakkat, William J. Guilford, Wei Xu, Brad O. Buckman, Marian Seto, Brain Griedel, David R. Light, Morrissey Michael M, David D. Davey, Kenneth J. Shaw, Damain O. Arnaiz, Amy Liang, Gary Phillips, Zuchun Zhao, Raju Mohan, Marc Whitlow
Publikováno v:
Acta Crystallographica Section D Biological Crystallography. 55:1395-1404
Factor Xa is a serine protease which activates thrombin (factor IIa) and plays a key regulatory role in the blood-coagulation cascade. Factor Xa is, therefore, an important target for the design of anti-thrombotics. Both factor Xa and thrombin share
Publikováno v:
The Journal of Organic Chemistry. 58:7848-7859
Synthesis of aldehydes 17 from D-arabinose and 31 from L-serine provided key precursors for the generation of highly functionalized dehydroamino acid derivatives upon condensation with glycyl phosphonates. Subsequent bromination and intramolecular ad
Publikováno v:
ChemInform. 23
Autor:
Sangku Lee, Zuchun Zhao
Publikováno v:
ChemInform. 30
Autor:
Zuchun Zhao, et al. et al.
Publikováno v:
ChemInform. 31